Gavi's response

Respond and protect: With COVID-19 now reported in almost all Gavi-eligible countries, the Vaccine Alliance is providing immediate funding to health systems, enabling countries to protect health care workers, perform vital surveillance and training, and purchase diagnostic tests.

Maintain, restore and strengthen: Gavi will support countries to adapt and restart immunisation services, rebuild community trust and catch up those who have been missed both before and during the pandemic, while also investing in strengthening immunisation systems to be more resilient and responsive to the communities they serve.

Ensure global equitable access: Gavi is co-leading COVAX, the global effort to securing a global response to COVID-19 that is effective and fair, using its unique expertise to help identify and rapidly accelerate development, production and delivery of COVID-19 vaccines so that anyone that needs them, gets them.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines.

Learn more

Situation reports

Historical updates concerning the impact of and response to the COVID-19 pandemic in Gavi-supported countries.

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.

Learn more

COVAX Facility

Key news

7 July 2021

The COVID-19 vaccine race

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19. Since the emergence of this novel coronavirus in December 2019, more than a dozen vaccines have started to be rolled…

15 October 2020

Taking the long view on vaccine markets

Gavi’s long-term approach to developing healthy markets for critical vaccines has led to greater stability and security, providing countries with the confidence that supplies will be available to meet their demand.

14 October 2020

2019 was a landmark year for countries co-financing their vaccine programmes

In 2019, a higher share of Gavi-supported countries than ever before met their co-financing obligations on time, thanks to strong political commitment.

13 October 2020

Strong systems for strong vaccine coverage

In 2019, countries delivered more than 230 million routine vaccinations, a record number, supported by unprecedented levels of health system funding from Gavi to support immunisation and protect the most vulnerable children. Here is what Gavi did…

28 September 2020

How market shaping works

The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.

25 September 2020

Experimental approaches to address post-transition risks

After transitioning out of Gavi support in 2017, the Republic of Moldova is mobilising champions and advocates to strengthen vaccine confidence – which is crucial to the success and sustainability of immunisation programmes.

24 September 2020

Typhoid: immunising against antimicrobial resistance

Typhoid fever is increasingly resistant to the main antibiotics used to treat it. Gavi is supporting a new vaccine to help control this deadly disease – and fight antimicrobial resistance.

23 September 2020

Gavi at UNGA: Global solidarity to defeat COVID-19 and create a better world for all

September 2020 marks the 75th anniversary of the United Nations General Assembly (UNGA). This year, the focus of the high-level General Debate is the importance of effective multilateralism.

23 September 2020

Leaders in the fight against infectious diseases

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

COVID-19 explored

View all

23 July 2021

TB prevention has relied on the same vaccine for 100 years. It’s time for innovation

BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.

23 July 2021

#VW Book Club

The #VaccinesWork Book Club is home to reviews, interviews and recommendations of some of our favourite books, podcasts, films and documentaries focused on vaccination and global health.

23 July 2021

How effective are COVID-19 vaccines in the real-world?

Real-world data is starting shed light on the performance of COVID-19 vaccines in less than perfect conditions.

23 July 2021

Q&A: Vaccine – The Human Story

Dr Annie Kelly, writer and host of a new podcast which tells the story of the smallpox vaccine, talks to #VaccinesWork.

22 July 2021

Review: The Panic Virus by Seth Mnookin

Mnookin’s 2011 investigation of the spread of anti-vax feeling is a pandemic-era must-read.

Last updated: 27 Apr 2021

Subscribe to our newsletter